Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of MBX 2109 in Healthy Adult Subjects

NCT05158335 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: MBX 2109 (Part A)
DRUG: MBX 2109 (Part B)
DRUG: Placebo

Sponsor

MBX Biosciences